200 related articles for article (PubMed ID: 38447103)
1. Statin Initiation and Risk of Incident Alzheimer Disease and Cognitive Decline in Genetically Susceptible Older Adults.
Rajan KB; Mcaninch EA; Wilson RS; Dhana A; Evans-Lacko S; Evans DA
Neurology; 2024 Apr; 102(7):e209168. PubMed ID: 38447103
[TBL] [Abstract][Full Text] [Related]
2. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep.
Lim AS; Yu L; Kowgier M; Schneider JA; Buchman AS; Bennett DA
JAMA Neurol; 2013 Dec; 70(12):1544-51. PubMed ID: 24145819
[TBL] [Abstract][Full Text] [Related]
3. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner.
Dratva MA; Banks SJ; Panizzon MS; Galasko D; Sundermann EE;
Biol Sex Differ; 2024 Jun; 15(1):45. PubMed ID: 38835072
[TBL] [Abstract][Full Text] [Related]
4. Age-varying association between statin use and incident Alzheimer's disease.
Li G; Shofer JB; Rhew IC; Kukull WA; Peskind ER; McCormick W; Bowen JD; Schellenberg GD; Crane PK; Breitner JC; Larson EB
J Am Geriatr Soc; 2010 Jul; 58(7):1311-7. PubMed ID: 20533968
[TBL] [Abstract][Full Text] [Related]
5. APOE ε4 and the risk for Alzheimer disease and cognitive decline in African Americans and Yoruba.
Hendrie HC; Murrell J; Baiyewu O; Lane KA; Purnell C; Ogunniyi A; Unverzagt FW; Hall K; Callahan CM; Saykin AJ; Gureje O; Hake A; Foroud T; Gao S
Int Psychogeriatr; 2014 Jun; 26(6):977-85. PubMed ID: 24565289
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
7. Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample.
Liu X; Beck T; Dhana K; Tangney CC; Desai P; Krueger K; Evans DA; Rajan KB
J Nutr Health Aging; 2024 May; 28(5):100211. PubMed ID: 38507884
[TBL] [Abstract][Full Text] [Related]
8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
9. Impact of the Apolipoprotein E ε4 Allele on the Relationship Between Healthy Lifestyle and Cognitive Decline: A Population-Based Study.
Dhana K; Aggarwal NT; Rajan KB; Barnes LL; Evans DA; Morris MC
Am J Epidemiol; 2021 Jul; 190(7):1225-1233. PubMed ID: 33585904
[TBL] [Abstract][Full Text] [Related]
10. The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.
Boyle PA; Buchman AS; Wilson RS; Kelly JF; Bennett DA
Neuroepidemiology; 2010; 34(1):43-9. PubMed ID: 19907191
[TBL] [Abstract][Full Text] [Related]
11. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
[TBL] [Abstract][Full Text] [Related]
12. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.
Beydoun MA; Beydoun HA; Kaufman JS; An Y; Resnick SM; O'Brien R; Ferrucci L; Zonderman AB
J Am Geriatr Soc; 2013 Apr; 61(4):525-34. PubMed ID: 23581910
[TBL] [Abstract][Full Text] [Related]
14. Dissociable influences of
Ge T; Sabuncu MR; Smoller JW; Sperling RA; Mormino EC;
Neurology; 2018 May; 90(18):e1605-e1612. PubMed ID: 29592889
[TBL] [Abstract][Full Text] [Related]
15. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
16. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
17. Association of APOE ε4 genotype and lifestyle with cognitive function among Chinese adults aged 80 years and older: A cross-sectional study.
Jin X; He W; Zhang Y; Gong E; Niu Z; Ji J; Li Y; Zeng Y; Yan LL
PLoS Med; 2021 Jun; 18(6):e1003597. PubMed ID: 34061824
[TBL] [Abstract][Full Text] [Related]
18. Statin users without an APOE-epsilon4 allele have increased insulin resistance.
VanFossen BT; Watson GS; Baker LD; Rhoads KW; Cholerton BA; Reger MA; Plymate SR; Schellenberg G; Craft S
J Alzheimers Dis; 2010; 19(4):1149-53. PubMed ID: 20308781
[TBL] [Abstract][Full Text] [Related]
19. Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans.
Hendrie HC; Hake A; Lane K; Purnell C; Unverzagt F; Smith-Gamble V; Murrell J; Ogunniyi A; Baiyewu O; Callahan C; Saykin A; Taylor S; Hall K; Gao S
Ethn Dis; 2015 Aug; 25(3):345-54. PubMed ID: 26673814
[TBL] [Abstract][Full Text] [Related]
20. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.
Bunce D; Fratiglioni L; Small BJ; Winblad B; Bäckman L
Neurology; 2004 Sep; 63(5):816-21. PubMed ID: 15365129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
